Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Uncategorized Posts

    Steppin for A Cause

    September 13th, 2022

    The Chondrosarcoma Foundation will host its Second Annual 5k Walk / Run to support research for Chondrosarcoma on October 15, 2022.

    We are honoring the legacy of Shayna Elise Kramer who lost her battle to chondrosarcoma at the young age of 28….

    Read Article

    Ricky Ashman is skydiving for the Chondrosarcoma Foundation in England on September 26


    On September 26, in England Ricky Ashman is raising £500 to Ricky by jumping a 15000ft sky dive to raise money and awareness for the Chondrosarcoma Foundation.

    I am doing a skydive to raise money for the Chondrosarcoma Foundation. It is a cause…

    Read Article

    New Research Article from William Cross PhD.

    September 6th, 2022

    William Cross, Ph.D. our board member from the UCL Cancer Center in London has been gracious enough to share his recently published article on:

    A genetic model for central chondrosarcoma
    evolution correlates with patient outcome

    It is William’s…

    Read Article

    Chondrosarcoma Foundation is Steppin for a Cause on Saturday, October 15

    August 27th, 2022

    The Chondrosarcoma Foundation will host its Second Annual 5k Walk / Run to support research for Chondrosarcoma on October 15, 2022.

    We are honoring the legacy of Shayna Elise Kramer who lost her battle to chondrosarcoma at the young age of 28….

    Read Article

    New cancer treatment offers hope to patients out of options

    August 24th, 2022

    By Andrew Gregory Health editor

    The Guardian
    2 days ago

    A new cancer treatment can stop the disease advancing in patients who are resistant to immunotherapy, doctors have discovered.

    Immunotherapy uses the immune system to target and kill cancer…

    Read Article

    Direct anti-cancer effect of oncostatin M on chondrosarcoma

    August 17th, 2022

    Emmanuelle David,Pierre Guihard,Bénédicte Brounais,Anne Riet,Céline Charrier,Séverine Battaglia,François Gouin,Stéphanie Ponsolle,Ronan Le Bot,Carl D. Richards … See all authors

    First published: 15 November…

    Read Article

    Jaimie Elliott is featured in Brighter Magazine

    July 30th, 2022

    Jamie Elliott a Chondrosarcoma Warrior extraordinaire. She is featured in this months Brighter Magazine for women who live their life with cancer. Jamie shows her spirit and how she overcomes obstacles by wining Pickleball Championships. Jamie is a…

    Read Article

    23andMe Phase 1 Trial is an Immunotherapy for treating advanced solid tumors


    A new Phase 1 Immunotherapy trial using genetic sequencing to address patients with metastatic solid tumors.

    Read Article

    Happy Heavenly 50th Birthday to Stanley Cornejo

    June 23rd, 2022

    Today is Stanley Tono Cornejo’s 50th Birthday. Please send good wishes and prayers to his family.

    Read Article

    Where to enroll in the Randomized, Placebo-Controlled, Phase 2 Trial,of INBRX-109 in Unresectable or Metastatic,Conventional Chondrosarcoma

    June 17th, 2022

    Inhibrx submitted the attached poster at the American Society of Clinical Oncology ASCO Conference last month. It addresses the Phase 2 study and the locations where they plan to have their our pivotal study for the medication INBRX-109. The best…

    Read Article